IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.8202
-0.0299 (-3.52%)
Dec 12, 2025, 9:34 AM EST - Market open

IO Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
596112466184-
Upgrade
Market Cap Growth
26.54%-51.06%86.88%-64.06%--
Upgrade
Enterprise Value
49-18-39-82268-
Upgrade
Last Close Price
0.850.921.882.306.40-
Upgrade
PB Ratio
65.041.290.930.480.87-
Upgrade
P/TBV Ratio
67.141.290.930.480.87-
Upgrade
Debt / Equity Ratio
19.890.040.020.02--
Upgrade
Quick Ratio
1.733.149.1813.5020.731.61
Upgrade
Current Ratio
2.013.339.3713.8821.521.85
Upgrade
Return on Equity (ROE)
-240.48%-106.00%-63.29%-40.74%-63.28%-2127.56%
Upgrade
Return on Assets (ROA)
-88.58%-54.47%-37.78%-23.87%-22.61%-84.11%
Upgrade
Return on Capital (ROIC)
-122.91%-64.45%-41.22%-25.25%-24.03%-129.47%
Upgrade
Return on Capital Employed (ROCE)
-425.30%-197.40%-67.70%-50.60%-19.50%-389.70%
Upgrade
Earnings Yield
-144.45%-157.55%-69.50%-107.82%-36.81%-
Upgrade
FCF Yield
-132.54%-135.94%-58.18%-91.16%-22.12%-
Upgrade
Buyback Yield / Dilution
-0.31%-51.31%-51.10%-564.62%-2346.74%-
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q